Antiviral activity against Ebola-like viruses infected in C57BL/6 mouse assessed as increase in mouse survival at 10 mg/kg, ip treated 1 hr before infection and on day 2, 5 of postinfection
Antiviral activity against Ebola-like viruses infected in C57BL/6 mouse assessed as increase in mouse survival at 10 mg/kg, ip single injection administered 2 days postinfection
Antiviral activity against Ebola-like viruses infected in C57BL/6 mouse assessed as serum alanine aminotransferase at 10 mg/kg, ip after 24 hrs measured on 2 days postinfection
Antiviral activity against Ebola-like viruses infected in C57BL/6 mouse assessed as serum aspartate aminotransferase at 10 mg/kg, ip after 24 hrs measured on 2 days postinfection
Antiviral activity against Ebola-like viruses infected in C57BL/6 mouse assessed as serum alkaline phosphatase at 10 mg/kg, ip after 24 hrs measured on 2 days postinfection
Antiviral activity against Ebola-like viruses infected in C57BL/6 mouse assessed as serum alanine aminotransferase at 10 mg/kg, ip after 24 hrs measured on 4 days postinfection
Antiviral activity against Ebola-like viruses infected in C57BL/6 mouse assessed as serum aspartate aminotransferase at 10 mg/kg, ip after 24 hrs measured on 4 days postinfection
Antiviral activity against Ebola-like viruses infected in C57BL/6 mouse assessed as serum alkaline phosphatase at 10 mg/kg, ip after 24 hrs measured on 4 days postinfection
Antiviral activity against Ebola-like viruses infected in C57BL/6 mouse assessed as serum alanine aminotransferase at 10 mg/kg, ip after 24 hrs measured on 6 days postinfection
Antiviral activity against Ebola-like viruses infected in C57BL/6 mouse assessed as serum aspartate aminotransferase at 10 mg/kg, ip after 24 hrs measured on 6 days postinfection
Antiviral activity against Ebola-like viruses infected in C57BL/6 mouse assessed as serum alkaline phosphatase at 10 mg/kg, ip after 24 hrs measured on 6 days postinfection